Next Capital Management LLC Cyto Dyn Inc. Transaction History

Next Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$0.15 - $0.3 $4,875 - $9,750	32,500 New	32,500 $6,000
Q4 2022 Jan 12, 2023	BUY	$0.19 - $0.46 $7,125 - $17,250	37,500 New	37,500 $8,000
Q1 2022 May 02, 2022	SELL	$0.37 - $1.02 $13,875 - $38,250	-37,500 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$1.27 - $2.46 $47,625 - $92,250	37,500 New	37,500 $74,000
Q2 2021 Oct 19, 2021	SELL	$1.67 - $3.98 $62,625 - $149,250	-37,500 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.12 - $7.15 $15,900 - $53,625	7,500 Added 25.0%	37,500 $101,000
Q2 2020 Jul 31, 2020	BUY	$2.25 - $8.77 $67,500 - $263,100	30,000 New	30,000 $170,000

271K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $122M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Next Capital Management LLC with notifications on news.